Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2015, Article ID 350829, 11 pages
http://dx.doi.org/10.1155/2015/350829
Research Article

Synthesis, Spectral Characterization, and Biochemical Evaluation of Antidiabetic Properties of a New Zinc-Diosmin Complex Studied in High Fat Diet Fed-Low Dose Streptozotocin Induced Experimental Type 2 Diabetes in Rats

1Department of Biochemistry, University of Madras, Guindy Campus, Chennai 600 025, India
2PG and Research Department of Chemistry, Pachaiyappa’s College, Chennai 600 030, India

Received 9 September 2015; Accepted 15 November 2015

Academic Editor: Saad Tayyab

Copyright © 2015 Veerasamy Gopalakrishnan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Panda and A. Kar, “Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside,” BioFactors, vol. 31, no. 3-4, pp. 201–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Cerf, “Beta cell dysfunction and insulin resistance,” Frontiers in Endocrinology, vol. 4, article 37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, “Global estimates of diabetes prevalence for 2013 and projections for 2035,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. N. S. Levitt, J. M. Katzenellenbogen, D. Brabshaw, M. N. Hoffman, and F. Bonnici, “The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa,” Diabetes Care, vol. 16, no. 4, pp. 601–607, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Herring, R. H. Jones, and D. L. Russell-Jones, “Hepatoselectivity and the evolution of insulin,” Diabetes, Obesity and Metabolism, vol. 16, no. 1, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Mukai, H. Tada, Y. Watanabe et al., “Lipids behavior and adverse effects for oral antidiabetic agents in patients with type2 diabetes treated with sulfonylureas alone based on systematic review,” Yakugaku Zasshi, vol. 127, no. 10, pp. 1747–1756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Katoh, Y. Matsumura, Y. Yoshikawa, H. Yasui, and H. Sakurai, “Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands,” Journal of Inorganic Biochemistry, vol. 103, no. 4, pp. 567–574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. R. Marita and K. L. Anilkumar, “Effect of vanadate on glycogen synthesis in dexamethasone-treated 3T3 adipocytes: evidence for a novel insulin sensitizing action,” Diabetes, Obesity and Metabolism, vol. 3, no. 4, pp. 271–278, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. C. Muñoz, A. Barberà, J. Domínguez, J. Fernàndez-Alvarez, R. Gomis, and J. J. Guinovart, “Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats,” Diabetes, vol. 50, no. 1, pp. 131–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Sakurai, “The discovery of vanadyl and zinc complexes for treating diabetes and metabolic syndromes,” Expert Opinion on Drug Discovery, vol. 2, no. 6, pp. 873–887, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Meyerovitch, Z. Farfel, J. Sack, and Y. Shechter, “Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action,” The Journal of Biological Chemistry, vol. 262, no. 14, pp. 6658–6662, 1987. View at Google Scholar · View at Scopus
  12. R. Jayawardena, P. Ranasinghe, P. Galappatthy, R. L. D. K. Malkanthi, G. R. Constantine, and P. Katulanda, “Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis,” Diabetology and Metabolic Syndrome, vol. 4, article 13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. A. Scott, “Crystalline insulin,” Biochemical Journal, vol. 28, no. 4, pp. 1592–1602.1, 1934. View at Publisher · View at Google Scholar
  14. L. Coulston and P. Dandona, “Insulin-like effect of zinc on adipocytes,” Diabetes, vol. 29, no. 8, pp. 665–667, 1980. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Frassinetti, G. L. Bronzetti, L. Caltavuturo, M. Cini, and C. D. Croce, “The role of zinc in life: a review,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 25, no. 3, pp. 597–610, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. B. L. Vallee and K. H. Falchuk, “The biochemical basis of zinc physiology,” Physiological Reviews, vol. 73, no. 1, pp. 79–118, 1993. View at Google Scholar · View at Scopus
  17. S. O. Emdin, G. G. Dodson, J. M. Cutfield, and S. M. Cutfield, “Role of zinc in insulin biosynthesis. Some possible zinc-insulin interactions in the pancreatic B-cell,” Diabetologia, vol. 19, no. 3, pp. 174–182, 1980. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Özcelik, M. Nazıroglu, M. Tunçdemir, Ö. Çelik, M. Öztürk, and M. F. Flores-Arce, “Zinc supplementation attenuates metallothionein and oxidative stress changes in kidney of streptozotocin-induced diabetic rats,” Biological Trace Element Research, vol. 150, no. 1–3, pp. 342–349, 2012. View at Publisher · View at Google Scholar
  19. Y. Liu, B. Batchuluun, L. Ho et al., “Characterization of zinc influx transporters (ZIPs) in pancreatic β cells,” Journal of Biological Chemistry, vol. 290, no. 30, pp. 18757–18769, 2015. View at Publisher · View at Google Scholar
  20. Y. V. Li, “Zinc and insulin in pancreatic beta-cells,” Endocrine, vol. 45, no. 2, pp. 178–189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Galanski, M. A. Jakupec, and B. K. Keppler, “Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches,” Current Medicinal Chemistry, vol. 12, no. 18, pp. 2075–2094, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. E. J. Corey, M. M. Mehrotra, and A. U. Khan, “Antiarthritic gold compounds effectively quench electronically excited singlet oxygen,” Science, vol. 236, no. 4797, pp. 68–69, 1987. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Yoshikawa, “Development research of new Zn complexes with anti-diabetic effect—structure-activity-related studies by displacement of coordination atom,” Yakugaku Zasshi, vol. 132, no. 9, pp. 1051–1055, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Sakurai and Y. Adachi, “The pharmacology of the insulinomimetic effect of zinc complexes,” BioMetals, vol. 18, no. 4, pp. 319–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Vijayaraghavan, S. I. Pillai, and S. P. Subramanian, “Design, synthesis and characterization of zinc-3 hydroxy flavone, a novel zinc metallo complex for the treatment of experimental diabetes in rats,” European Journal of Pharmacology, vol. 680, no. 1–3, pp. 122–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Sendrayaperumal, S. Iyyam Pillai, and S. Subramanian, “Design, synthesis and characterization of zinc-morin, a metal flavonol complex and evaluation of its antidiabetic potential in HFD-STZ induced type 2 diabetes in rats,” Chemico-Biological Interactions, vol. 219, pp. 9–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Uma Maheswari, S. Iyyam Pillai, and S. P. Subramanian, “Zinc-silibinin complex: synthesis, spectral characterization and biochemical evaluation of antidiabetic potential in high fat fed low dose STZ induced type 2 diabetic rats,” Journal of Chemical and Pharmaceutical Research, vol. 7, no. 3, pp. 2051–2064, 2015. View at Google Scholar
  28. B. H. Havsteen, “The biochemistry and medical significance of the flavonoids,” Pharmacology and Therapeutics, vol. 96, no. 2-3, pp. 67–202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. Rice-Evans, N. J. Miller, and G. Paganga, “Structure-antioxidant activity relationships of flavonoids and phenolic acids,” Free Radical Biology and Medicine, vol. 20, no. 7, pp. 933–956, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. J. P. Cornard and J. C. Merlin, “Comparison of the chelating power of hydroxyflavones,” Journal of Molecular Structure, vol. 651–653, pp. 381–387, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Campanero, M. Escolar, G. Perez, E. Garcia-Quetglas, B. Sadaba, and J. R. Azanza, “Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: application to a clinical pharmacokinetic study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 51, no. 4, pp. 875–881, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. O. A. Oesterle and G. Wander, “Naturally occurring flavonic glycoside; rhamnoglycoside of diosmetin, q.v. Isolation from various plant sources,” Helvetica Chimica Acta, vol. 8, article 519, 1925. View at Google Scholar
  33. G. Hitzenberger, “Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg,” Wiener Medizinische Wochenschrift, vol. 147, no. 18, pp. 409–412, 1997. View at Google Scholar
  34. W. Thanapongsathorn and T. Vajrabukka, “Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids,” Diseases of the Colon and Rectum, vol. 35, no. 11, pp. 1085–1088, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. A. K. Ratty and N. P. Das, “Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship,” Biochemical Medicine and Metabolic Biology, vol. 39, no. 1, pp. 69–79, 1988. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Tanaka, H. Kohno, and H. Mori, “Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds,” Asian Pacific Journal of Cancer Prevention, vol. 2, no. 3, pp. 165–177, 2001. View at Google Scholar · View at Scopus
  37. M. Tahir, M. U. Rehman, A. Lateef et al., “Diosmin protects against ethanol-induced hepatic injury via alleviation of inflammation and regulation of TNF-α and NF-κB activation,” Alcohol, vol. 47, no. 2, pp. 131–139, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Srinivasan and L. Pari, “Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats,” Chemico-Biological Interactions, vol. 195, no. 1, pp. 43–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. J. P. Cornard, L. Vrielynck, J. C. Merlin, and J. C. Wallet, “Structural and vibrational study of 3-hydroxyflavone and 3-methoxyflavone,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 51, no. 5, pp. 913–923, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-X. Zhang and P. Mei, “Synthesis of morin-zinc(II) complex and its interaction with serum albumin,” Biological Trace Element Research, vol. 143, no. 2, pp. 677–687, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Tan, B. Wang, and L. Zhu, “DNA binding, cytotoxicity, apoptotic inducing activity, and molecular modeling study of quercetin zinc(II) complex,” Bioorganic and Medicinal Chemistry, vol. 17, no. 2, pp. 614–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. N. E. Ikeda, E. M. Novak, D. A. Maria, A. S. Velosa, and R. M. Pereira, “Synthesis, characterization and biological evaluation of Rutin-zinc(II) flavonoid-metal complex,” Chemico-Biological Interactions, vol. 239, pp. 184–191, 2015. View at Google Scholar
  43. K. H. Thompson, B. D. Liboiron, Y. Sun et al., “Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential,” Journal of Biological Inorganic Chemistry, vol. 8, no. 1-2, pp. 66–74, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Vargová, J. Kotek, J. Rudovský et al., “Ternary complexes of zinc(II), cyclen and pyridinecarboxylic acids,” European Journal of Inorganic Chemistry, no. 25, pp. 3974–3987, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Bartoli, G. P. Fra, and G. P. C. Schianca, “The oral glucose tolerance test (OGTT) revisited,” European Journal of Internal Medicine, vol. 22, no. 1, pp. 8–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Hassid and S. Abraham, “Chemical procedures for analysis of polysaccharides,” in Methods in Enzymology, S. Colowick and N. Kaplan, Eds., vol. 3, pp. 34–36, Academic Press, New York, NY, USA, 1957. View at Google Scholar
  49. P. Trinder, “Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen,” Journal of Clinical Pathology, vol. 22, no. 2, pp. 158–161, 1969. View at Publisher · View at Google Scholar · View at Scopus
  50. S. S. Nayak and T. N. Pattabiraman, “A new colorimetric method for the estimation of glycosylated hemoglobin,” Clinica Chimica Acta, vol. 109, no. 3, pp. 267–274, 1981. View at Publisher · View at Google Scholar · View at Scopus
  51. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  52. M. L. Scott and C. Beffa, “A rapid method for the estimation of urea in biologic fluids,” American Journal of Clinical Ppathology, vol. 21, no. 3, pp. 275–281, 1951. View at Google Scholar · View at Scopus
  53. J. Brod and J. H. Sirota, “The renal clearance of endogenous ‘creatinine’ in man,” Journal of Clinical Investigation, vol. 27, no. 5, pp. 645–654, 1948. View at Publisher · View at Google Scholar
  54. J. King, “Transaminases: alanine and aspartate transaminases,” in Practical Clinical Enzymology, pp. 363–395, D. Van Nostrand Company, London, UK, 1965. View at Google Scholar
  55. J. King, “The hydrolases-acid and alkaline phosphatases,” in Practical Clinical Enzymology, pp. 199–208, D. Van Nostrand Company, London, UK, 1965. View at Google Scholar
  56. L. F. Leloir and S. H. Goldemberg, “Glycogen synthetase from rat liver,” in Methods in Enzymology, S. P. Colowick and N. O. Kaplan, Eds., vol. 5, pp. 145–146, Academic Press, New York, NY, USA, 1962. View at Google Scholar
  57. M. Cornblath, P. J. Randle, A. Parmeggiani, and H. E. Morgan, “Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart,” The Journal of Biological Chemistry, vol. 238, pp. 1592–1597, 1963. View at Google Scholar · View at Scopus
  58. M. L. Godino-Salido, M. D. Gutiérrez-Valero, R. López-Garzón, and J. M. Moreno-Sánchez, “Zn(II) complexes with thiopyrimidine derivatives: solution study, synthesis and crystal structure of a zig-zag chain zinc(II) complex with the ligand 4,6-dimethyl-2-thiopyrimidine,” Inorganica Chimica Acta, vol. 221, no. 1-2, pp. 177–181, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. J.-S. Choi, J. J. Braymer, S. K. Park, S. Mustafa, J. Chae, and M. H. Lim, “Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation,” Metallomics, vol. 3, no. 3, pp. 284–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J. J. Braymer, J.-S. Choi, A. S. Detoma et al., “Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species,” Inorganic Chemistry, vol. 50, no. 21, pp. 10724–10734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. V. G. Yuen, P. Caravan, L. Gelmini et al., “Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands,” Journal of Inorganic Biochemistry, vol. 68, no. 2, pp. 109–116, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Ai, Y. Ma, J. Wang, and Y. Li, “Preparation, physicochemical characterization and in-vitro dissolution studies of diosmin-cyclodextrin inclusion complexes,” Iranian Journal of Pharmaceutical Research, vol. 13, no. 4, pp. 1115–1123, 2014. View at Google Scholar · View at Scopus
  63. F. Hernandez Hernandez, J. Medina Escriche, and M. T. Gasco Andreu, “Enhancement of the fluorescence of the zinc-morin complex by a non-ionic surfactant,” Talanta, vol. 33, no. 6, pp. 537–540, 1986. View at Publisher · View at Google Scholar · View at Scopus
  64. J. L. Nieto and A. M. Gutierrez, “1H NMR spectra at 360 MHz of diosmin and hesperidin in DMSO solution,” Spectroscopy Letters, vol. 19, no. 5, pp. 427–434, 1986. View at Publisher · View at Google Scholar
  65. R. K. Markham and V. M. Chari, “Carbon-13 NMR spectroscopy of flavonoids,” in The Flavonoids, pp. 19–134, Springer, New York, NY, USA, 1982. View at Publisher · View at Google Scholar
  66. D. A. Scott and A. M. Fisher, “The insulin and the zinc content of normal and diabetic pancreas,” The Journal of Clinical Investigation, vol. 17, no. 6, pp. 725–728, 1938. View at Publisher · View at Google Scholar
  67. L. Pari and S. Srinivasan, “Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats,” Biomedicine & Pharmacotherapy, vol. 64, no. 7, pp. 477–481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. M. J. Reed, K. Meszaros, L. J. Entes et al., “A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat,” Metabolism, vol. 49, no. 11, pp. 1390–1394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. M. A. Abdul-Ghani, D. Tripathy, and R. A. DeFronzo, “Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose,” Diabetes Care, vol. 29, no. 5, pp. 1130–1139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. D. Jain, M. K. Bansal, R. Dalvi, A. Upganlawar, and R. Somani, “Protective effect of diosmin against diabetic neuropathy in experimental rats,” Journal of Integrative Medicine, vol. 12, no. 1, pp. 35–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. B. A. Pederson, J. M. Schroeder, G. E. Parker, M. W. Smith, A. A. DePaoli-Roach, and P. J. Roach, “Glucose metabolism in mice lacking muscle glycogen synthase,” Diabetes, vol. 54, no. 12, pp. 3466–3473, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. E. H. Harris, “Elevated liver function tests in type 2 diabetes,” Clinical Diabetes, vol. 23, no. 3, pp. 115–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. N. H. Cho, H. C. Jang, H. C. Sung et al., “Abnormal liver function test predicts type 2 diabetes: a community-based prospective study,” Diabetes Care, vol. 30, no. 10, pp. 2566–2568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Møller and K. S. Nair, “Diabetes and protein metabolism,” Diabetes, vol. 57, no. 1, pp. 3–4, 2008. View at Publisher · View at Google Scholar · View at Scopus